A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

Clinical trial NCT06011733 · COMPLETED

Trial details

NCT number: NCT06011733
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Plaque Psoriasis Moderate to Severe Chronic Plaque Psoriasis

Start date: 2023-10-31
Primary completion: 2025-02-05
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.